Effect of calcium supplements on the oral bioavailability of moxifloxacin in healthy male volunteers.

Stass, H; Wandel, C; Delesen, H; Möller, J G

Stass, H; Wandel, C; Delesen, H; Möller, J G.

Affiliation

Stass H; Pharma Research Centre, Institute of Clinical Pharmacology, Bayer AG, Wuppertal, Germany. Heino.Stass.hs@bayer-ag.de

Clin Pharmacokinet ; 40 Suppl 1: 27-32, 2001.

Article in En | MEDLINE | ID: mdl-11352439

Subject(s)

Anti-Infective Agents/pharmacokinetics; Aza Compounds; Calcium/pharmacology; Fluoroquinolones; Quinolines; Administration, Oral; Adult; Analysis of Variance; Area Under Curve; Biological Availability; Cross-Over Studies; Drug Interactions; Half-Life; Humans; Intestinal Absorption/drug effects; Linear Models; Male; Moxifloxacin

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Quinolines / Aza Compounds / Calcium / Fluoroquinolones / Anti-Infective Agents Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Adult / Humans / Male Language: En Journal: Clin Pharmacokinet Year: 2001 Document type: Article

Search on Google

XML

PubMed Links